Insys Therapeutics, manufacturer of the synthetic opioid medication fentanyl, made headlines recently when it donated half a million dollars to the anti-cannabis legalization effort in Arizona. Fentanyl is a potent and highly addictive pain killer helping fuel the country’s opioid epidemic and skyrocketing overdose rates. Presumably, Insys is funding anti-legalization efforts because legal cannabis represents […]

by

Insys Therapeutics, manufacturer of the synthetic opioid medication fentanyl, made headlines recently when it donated half a million dollars to the anti-cannabis legalization effort in Arizona. Fentanyl is a potent and highly addictive pain killer helping fuel the country’s opioid epidemic and skyrocketing overdose rates. Presumably, Insys is funding anti-legalization efforts because legal cannabis represents […]

by

Ohio is now one of 26 states to legalize medical marijuana, and a committee appointed by the governor will begin drafting implementation rules this month. Members say one priority is to ensure the state protects the community and the patients who will ultimately use the marijuana products. “We don’t want this to turn into another […]

by

I used cannabis for nausea without realizing it might actually have been the cause of it. Cannabinoid hyperemesis syndrome (also known as cannabis hyperemesis syndrome, or CHS) is a recently discovered, poorly understood condition theoretically caused by heavy, long-term cannabis use. Its acute “hyperemetic” phase is characterized by vomiting, nausea, severe gastrointestinal discomfort, and compulsive […]

by

Insys Therapeutics, manufacturer of the synthetic opioid medication fentanyl, made headlines recently when it donated half a million dollars to the anti-cannabis legalization effort in Arizona. Fentanyl is a potent and highly addictive pain killer helping fuel the country’s opioid epidemic and skyrocketing overdose rates. Presumably, Insys is funding anti-legalization efforts because legal cannabis represents […]

by

SAN DIEGO, CA–(Marketwired – October 11, 2016) – Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that its subsidiary HempMeds® is exhibiting at the Oct. 14-15 New West Summit in San Francisco. Meanwhile, parent advocates Katiele and Norberto Fischer are visiting the U.S. for the first time to speak on an Oct. 14 panel at […]

by

Enthusiasts of the supplement kratom, derived from the leaves of the Mitragyna Speciosa tree, have been giving the DEA, the FDA and us a hard time lately, in the case of the government because they want to ban it  due to a huge surge in poisonings and in our case since we called for the substance to be regulated just […]

by

Enthusiasts of the supplement kratom, derived from the leaves of the Mitragyna Speciosa tree, have been giving the DEA, the FDA and us a hard time lately, in the case of the government because they want to ban it  due to a huge surge in poisonings and in our case since we called for the substance to be regulated just […]

by

Enthusiasts of the supplement kratom, derived from the leaves of the Mitragyna Speciosa tree, have been giving the DEA, the FDA and us a hard time lately, in the case of the government because they want to ban it  due to a huge surge in poisonings and in our case since we called for the substance to be regulated just […]

by

Vitality Biopharma Inc(OTCMKTS:VBIO) has been running fast up the chart in recent weeks as pot stocks heat up across the board leading up to November 8. VBIO was trading as low as $0.38 last month and has hit recent highs over $1.75. VBIO operates in the red hot Marijuana industry that has quickly turned into […]

by

The article is published in conjunction with Leafly. On Monday cannabidiol (CBD) producers and distributors in the UK started to receive letters from the Medicines and Healthcare Products Regulatory Agency (MHRA) demanding that they cease to sell, supply, promote, advertise or process orders for CBD products within 28 days. The letters stated that CBD now satisfies the definition […]

by

The article is published in conjunction with Leafly. On Monday cannabidiol (CBD) producers and distributors in the UK started to receive letters from the Medicines and Healthcare Products Regulatory Agency (MHRA) demanding that they cease to sell, supply, promote, advertise or process orders for CBD products within 28 days. The letters stated that CBD now satisfies the definition […]

by

Getty As medical marijuana becomes legal in more states across the country, there’s been a spike in public interest to see whether cannabis can effectively treat mood disorders such as anxiety, depression, and psychosis that are commonly associated with bipolar disorder. Unfortunately, there are conflicts in scientific consensus for both supporting and opposing views of […]

by

Hilary Bricken For true marijuana connoisseurs, tetrahydrocannabinol (THC) isn’t the only thing in marijuana about which to rave. There’s also the increasingly popular cannabidiol (CBD) part of the plant. CBD is a compound in marijuana with mild to no psychoactive effect. It is frequently used to prevent seizures and there also have been some promising […]

by

Editor’s Note: This story was produced in conjunction with Volteface.  On Monday cannabidiol (CBD) producers and distributors in the UK started to receive letters from the Medicines and Healthcare Products Regulatory Agency (MHRA) demanding that they cease to sell, supply, promote, advertise or process orders for CBD products within 28 days. The letters stated that CBD now satisfies […]

by